Experts assess what the freeze means for the global development sector and communities dependent on US aid, and what should ...

Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...

With recent cuts to foreign aid, including programs like PEPFAR, thousands of Africans living with HIV face an uncertain ...

The government, through the Ministry of Health, assures the public that ARV drugs are not sold and remain sufficiently ...

Gilead beat consensus estimates in Q4 with $7.6 billion in revenue, driven largely by its HIV drug Biktarvy and CAR T therapies Trodelvy and Yescarta.

In a public statement issued on Saturday, February 8, 2024, the ministry assured the public that ARV supplies remain ...

Motsoaledi dreads what stopping the distribution of antiretroviral drugs, or ARVs, would mean. "Nobody must stop taking ARVs ...

Freezing aid funds jeopardizes critical healthcare programs and security cooperation with important US allies around the ...

In response to the recent suspension of United States Agency for International Development (USAID) funding, President John ...